At Akums, we believe that innovation is key to success in the pharmaceutical industry. We are constantly pushing boundaries and exploring new technologies to develop innovative solutions that meet the needs of our clients and addressing gaps in the market. Our state-of-the-art research and development facility is equipped with the latest tools and technologies to support our innovation efforts. We also encourage the culture of creativity and collaboration among our team members to drive innovation at every level of our organization.
Smarter way of delivering therapeutic doses with reduced excipient burden
Self preserved eye drops with ionic buffers
Stable drug release profile for sustained release formulations
Enhanced protection for Probiotics with unique protective layer
Vaginal Effervescent tablet for local action
Polysaccharide coating for spore stability at varying pH
Enhanced solubility & bioavailability of hydrophobic drugs
For better permeability in ophthalmic drugs
For less viscous, less painful and more efficacious injections
Better drug penetration through the skin
Enhanced absorption of lipophilic drugs by conversion into micelles
Reduction of the disintegration time of dispersible tablets
Novel tablet in tablet technology especially developed for PPI’s
Offers drug particles in NANO range for greater absorption
Novel Alcohol-free formulations
Extended drug retention time on the corneal surface
Converts emulsion in droplets for greater absorption
Enhanced absorption of herbs and bioactive extracts
AKUMS innovative maneuvers spread across all stages of the life cycles of a product and concept. When it comes to novel ideas and executions, there is no limit that the company marks as the limit. There are various steps and utilization of resources, to create innovation, be it for a product, technology, process, or concept, to get the better formulations in the market. Our valued partners form an innovation ecosystem and connect us together to work transparently for the same goal and share success.
"If we think we can do it alone, we are not thinking big enough. We’re innovating with partners to bring together bright minds, big ideas, and disruptive technology. "
Are you working on idea that could match our collective ambitions?
BILASTINE + MONTELUKAST ODT FIRST TIME IN WORLD
CEFIXIME + OFLOXACIN
ACECLOFENAC + RABEPRAZOLE